Prime Therapeutics announces Ken Bodmer as chief financial officer
EAGAN, Minn., Dec. 5, 2023 /PRNewswire/ -- Today, Prime Therapeutics LLC/Magellan Rx Management LLC (Prime/MRx) announces that it has appointed Ken Bodmer as chief financial officer (CFO), effective Dec. 4, 2023.
- EAGAN, Minn., Dec. 5, 2023 /PRNewswire/ -- Today, Prime Therapeutics LLC/Magellan Rx Management LLC (Prime/MRx) announces that it has appointed Ken Bodmer as chief financial officer (CFO), effective Dec. 4, 2023.
- "Ken is an extraordinary leader with a deep understanding of the markets we serve and brings a unique blend of financial and operational expertise coupled with a proven track record of success," said Mostafa Kamal , president and chief executive officer at Prime.
- Bodmer has more than 20 years of experience in business and financial leadership in both pharmacy benefit management and specialty pharmacy.
- His previous experience also includes both CFO and chief operating officer roles at Accredo, as well as key financial leadership roles at Medco (now Express Scripts) and Catamaran (now OptumRx).